Form 8-K PORTOLA PHARMACEUTICALS For: Feb 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Portola Pharma (PTLA) Misses Q4 EPS by 11c
February 26, 2016 8:08 AM ESTPortola Pharma (NASDAQ: PTLA) reported Q4 EPS of ($1.23), $0.11 worse than the analyst estimate of ($1.12). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $2.43 million.
For earnings history and earnings-related data on Portola Pharma (PTLA) click here.
... More